DPD3 Stock Overview
A urologic oncology company, focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Imagin Medical Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.0005 |
| 52 Week High | CA$0.13 |
| 52 Week Low | CA$0.0005 |
| Beta | 1.15 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -98.81% |
| 3 Year Change | -99.85% |
| 5 Year Change | -99.95% |
| Change since IPO | -99.98% |
Recent News & Updates
Recent updates
Shareholder Returns
| DPD3 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0% | 1.5% | 2.6% |
| 1Y | -98.8% | -6.0% | 13.4% |
Return vs Industry: DPD3 underperformed the German Medical Equipment industry which returned -10.8% over the past year.
Return vs Market: DPD3 underperformed the German Market which returned 2% over the past year.
Price Volatility
| DPD3 volatility | |
|---|---|
| DPD3 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.5% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: DPD3's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine DPD3's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | n/a | Jim Hutchens | imaginmedical.com |
Imagin Medical Inc., a urologic oncology company, focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. It offers the i/Blue Imaging System, which detects bladder cancer with advanced proprietary optics and light sensors; and enCage Coil, a disposable and focal therapy precision ablation device for use in the treatment of prostate cancer. The company is also developing technologies to visualize and treat urologic cancers through minimally invasive surgery, including bladder and prostate cancer.
Imagin Medical Inc. Fundamentals Summary
| DPD3 fundamental statistics | |
|---|---|
| Market cap | €110.31k |
| Earnings (TTM) | -€2.26m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs DPD3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DPD3 income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$3.32m |
| Earnings | -CA$3.32m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.31 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -91.8% |
How did DPD3 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/05/04 19:35 |
| End of Day Share Price | 2024/02/05 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2022/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Imagin Medical Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|